STOCK TITAN

PACS Group CEO sells 51,887 shares in plan

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

PACS Group, Inc. (PACS) disclosed that reporting person Murray Jason Hulse, its Co-Founder, CEO & Chairman and a ten percent owner, sold a total of 51,887 shares of common stock in several open-market or private transactions on September 4, 8 and 9, 2026 under a Rule 10b5-1 trading plan adopted on May 18, 2026. The reported per-share prices are weighted averages, with the underlying trades executed within disclosed price ranges around the low- to mid-$40s per share.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Murray Jason Hulse
Role Co-Founder, CEO & Chairman
Sold 51,887 shs ($2.24M)
Type Security Shares Price Value
Sale Common Stock F1, F6 4,758 $43.3264 $206K
Sale Common Stock F1, F4 3,056 $42.8001 $131K
Sale Common Stock F1, F5 21,001 $43.5946 $916K
Sale Common Stock F1, F2 22,829 $42.6832 $974K
Sale Common Stock F1, F3 243 $43.1445 $10K
Holdings After Transaction: Common Stock — 54,574,866 shares (Direct)
Footnotes (6)
  1. F1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
  2. F2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.11 to $43.10 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. F3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.14 to $43.16 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. F4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.25 to $43.22 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. F5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.29 to $43.90 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  6. F6. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.89 to $43.66 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Total shares sold 51,887 shares Aggregate common stock sales reported for September 4–9, 2026
Shares sold September 4, 2026 22,829 shares; 243 shares Two transactions of common stock on September 4, 2026
Shares sold September 8, 2026 3,056 shares; 21,001 shares Two transactions of common stock on September 8, 2026
Shares sold September 9, 2026 4,758 shares Single common stock sale reported for September 9, 2026
Weighted average price example (Sept. 4 large block) $42.6832 per share 22,829-share sale; trades ranged from $42.11 to $43.10 per share
Weighted average price example (Sept. 8 large block) $43.5946 per share 21,001-share sale; trades ranged from $43.29 to $43.90 per share
Rule 10b5-1 trading plan regulatory
"The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Securities and Exchange Commission regulatory
"the staff of the Securities and Exchange Commission, upon request, full information"
A national government agency that enforces rules for buying, selling and disclosing information about stocks and other investments, acting like a referee and scorekeeper for financial markets. It requires companies to share clear, regular financial and business information and investigates fraud or rule-breaking, which matters to investors because those rules and disclosures help ensure fair prices, reduce hidden risks and make it easier to compare investment choices.

FAQ

What insider activity did PACS Group, Inc. (PACS) report in this Form 4?

PACS Group, Inc. reported that Co-Founder, CEO & Chairman Murray Jason Hulse sold 51,887 shares of common stock in multiple transactions on September 4, 8 and 9, 2026. All transactions were reported as sales of common stock held directly.

At what prices were the PACS shares sold by the CEO in this filing?

The reported prices are weighted average prices. For example, sales on September 4, 2026 were executed within ranges of $42.11–$43.10 and $43.14–$43.16 per share, and September 8–9 sales were within ranges of roughly $42.25–$43.90 per share.

How many PACS shares did the CEO sell on each reported date?

On September 4, 2026, Murray Jason Hulse sold 22,829 shares in one transaction and 243 shares in another. On September 8, he sold 3,056 and 21,001 shares in two transactions. On September 9, he sold 4,758 shares.

Were the PACS (PACS) insider sales made under a Rule 10b5-1 plan?

Yes. A footnote states the sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Murray Jason Hulse on May 18, 2026, and the Rule 10b5-1 checkbox for the filing is affirmed.

Does the Form 4 state how many PACS shares the CEO owns after these sales?

No. For each reported transaction, the field for shares owned following the transaction is blank, so this filing does not state Murray Jason Hulse’s post-transaction common stock holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Murray Jason Hulse

(Last)(First)(Middle)
C/O PACS GROUP, INC.
90 S. 400 W. SUITE 700

(Street)
SALT LAKE CITY UTAH 84101

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
PACS Group, Inc. [ PACS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
Co-Founder, CEO & Chairman
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
09/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock09/04/2026S(1)22,829D$42.6832(2)54,603,924D
Common Stock09/04/2026S(1)243D$43.1445(3)54,603,681D
Common Stock09/08/2026S(1)3,056D$42.8001(4)54,600,625D
Common Stock09/08/2026S(1)21,001D$43.5946(5)54,579,624D
Common Stock09/09/2026S(1)4,758D$43.3264(6)54,574,866D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 18, 2026.
2. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.11 to $43.10 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.14 to $43.16 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.25 to $43.22 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $43.29 to $43.90 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
6. The price reported in Column 4 is a weighted average price. The securities were sold in multiple transactions at prices ranging from $42.89 to $43.66 per share of common stock. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Remarks:
/s/ John Mitchell, Attorney-in-Fact09/09/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading